---
schema_version: "secwatch.filing_event.v1"
accession: "0001110803-22-000045"
form_type: "8-K"
ticker: "ILMN"
cik: "0001110803"
company_name: "ILLUMINA, INC."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T07:56:01.284733+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Illumina Q3 revenue $1.12B (+1% YoY); GAAP EPS -$24.26 on $3.91B GRAIL goodwill impairment

## Summary
- GAAP diluted loss per share of $(24.26) vs. income of $2.08 in Q3 2021, driven by $3.91B goodwill impairment for GRAIL segment.
- Non-GAAP diluted EPS of $0.34, down from $1.45; revenue $1.115B, up 1% reported and 3% constant currency.
- Full-year FY2022 guidance: revenue flat to +1% YoY; GAAP EPS loss $(26.56)-$(26.41); non-GAAP EPS $2.35-$2.50.
- 50 NovaSeq X orders received; management expects macro headwinds to continue into 2023.
- Consolidated GRAIL results included; GAAP gross margin 64.3% vs 69.5% YoY; operating margin -327.9%.

## SEC filing metadata
- accession: 0001110803-22-000045
- form_type: 8-K
- ticker: ILMN
- cik: 0001110803
- company_name: ILLUMINA, INC.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1110803/000111080322000045/0001110803-22-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1110803/000111080322000045/ilmn-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001110803-22-000045
- JSON: https://secwatch.observer/filing/0001110803-22-000045.json
- Plain text: https://secwatch.observer/filing/0001110803-22-000045.txt

## Key facts
- Earnings Releases
  ILLUMINA, INC. reported third quarter ended October 2, 2022 results: revenue $1.12 billion, net income $ (3,816), EPS $(24.26). Guidance initiated.
  - Period: third quarter ended October 2, 2022
  - Revenue: $1.12 billion
  - Net income: $ (3,816)
  - EPS: $(24.26)
  - Guidance: initiated
  - Result: reported results
  source text: Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022 • Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis • GAAP diluted loss per share of $(24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share for Q3 2022 includes goodwill impairment of $3.91 billion related to the GRAIL segment • Non-GAAP diluted earnings per share of $0.34 for Q3 2022, compared to non-GAAP diluted earnings per share of $1.45 for Q3 2021 • Expect full year revenue for fiscal year 2022 to be flat to 1% higher compared to fiscal year 2021, primarily reflecting year-to-date growth in sequencing consumables revenue, largely offset by a fourth quarter decline in select research project sample volume; delayed purchases ahead of the upcoming availability of NovaSeq X and from customer inventory and capital management; and incremental foreign exchange headwinds • Expect GAAP diluted loss per share of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1110803/000111080322000045/0001110803-22-000045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.